Beta cell function and response to treatment in Nigerians with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 69, Issue 2, 2005, Pages 196-204

  Oli, J M ^a,b   Adeyemo, A A ^b   Okafor, G O ^a   Ofoegbu, E N ^a   Onyenekwe, B ^a   Chukwuka, C J ^a   Chen, G ^b   Chen, Y ^b   Doumatey, A P ^b   Aje, T O ^b   Rotimi, C N ^b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Beta cell function; C peptide; Nigerians; Type 2 Diabetes mellitus

Indexed keywords

BIGUANIDE; C PEPTIDE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLUCAGON; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CONTROL; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREDICTION; PROSPECTIVE STUDY; TEACHING HOSPITAL;

BLOOD GLUCOSE; BODY MASS INDEX; BODY SIZE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; NIGERIA;

EID: 21744457062     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.12.006     Document Type: Article

References (31)

1. A. Aro Role of plasma C-peptide determination in the management of type 11 diabetes Acta Endocrinol. Suppl. 272 1985 79 82
2. B. Solnica, J.W. Naskalski, and J. Sieradzki Analytic performance of glucometers used for routine glucose self-monitoring of diabetic patients Clin. Chim. Acta 331 2003 29 35
3. E.O. Udezue, A.C. Ezeoke, and J.M. Oli Use of portable glucose meter in a Nigerian diabetic clinic Trop. Geogr. Med. 41 1989 141 145
4. O. Hother-Nielsen, O. Faber, N.S. Sørensen, and H. Beck-Nielsen Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables Diabetes Care 11 1988 531 537
5. M.J. Taverna, N. Pacher, F. Bruzzo, G. Slama, and J.L. Selam Beta-cell function evaluated by HOMA as a predictor of secondary Sulphonylurea failure in Type 2 diabetes Diabet. Med. 18 2001 584 588
6. E.S. Siraj, S.S. Reddy, W.A. Scherbaum, J. Abdulkadir, J.P. Hammel, and C. Faiman Basal and postglucagon C-Peptide levels in Ethiopians with diabetes Diabetes Care 25 2002 453 457
7. S. Arnold-Larson, S. Madsbad, and C. Kühl Reproducibility of the glucagon test Diabet. Med. 4 1987 299 303
8. M.I. Harris, C.C. Cowie, K. Gu, M.E. Francis, K. Flegal, and M.S. Eberhardt Higher fasting insulin but lower fasting C-peptide levels in African Americans in the US population Diabet. Metab. Res. Rev. 18 2002 149 155
9. R. Shires, B.I. Joffe, and H.C. Seftel Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects S. Afr. Med. J. 67 1985 845 847
10. M.A. Omar, and A.C. Asmal C-peptide response to glucagons in black and Indian insulin-dependent diabetics S. Afr. Med. J. 61 1982 395 397
11. W.J. Kalk, J. Joannou, S. Ntsepo, I. Mahomed, P. Mahanlal, and P.J. Becker Ethnic differences in the clinical and laboratory associations with retinopthy in adult onset diabetes: studies in patients of African, European and Indian origins J. Intern. Med. 241 1997 31 37
12. C.N. Hales, D.J. Barker, and P.M. Clark Fetal and infant growth and impaired glucose tolerance at age 64 BMJ 303 1991 1019 1022
13. G.R. Alexander, M. Kogan, D. Bader, W. Carlo, M. Allen, and J. Mor US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, Hispanics and blacks Pediatrics 111 2003 e61 e66
14. P. Steer, M.A. Alam, J. Wadsworth, and A. Welch Relation between maternal haemoglobin concentration and birth weight in different ethnic groups BMJ 310 1995 489 491
15. C.N. Hales, and D.J. Barker Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia 35 1992 595 601
16. J.M. Evans, P.T. Donnan, and A.D. Morrist Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes Diabet. Med. 19 2002 685 688
17. P. Clauson, R. Linnarsson, A. Gottsater, G. Sundkvist, and V. Grill Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden Diabet. Med. 11 1994 794 801
18. G. Schernthaner, S. Hink, H.P. Kopp, B. Muzyka, G. Streit, and A. Kroiss Progress in the characterization of slowly progressive autoimmune diabetes in adult patients (LADA or type 1,5 diabetes) Exp. Clin. Endocrinol. Diabetes 109 Suppl 2 2001 S94 S108
19. R.A. DeFronzo Lilly lecture 1987: the triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM Diabetes 37 1988 667 687
20. N. Kaiser, G. Leibowitz, and R. Nesher Glucotoxicity and beta-cell failure in type 2 diabetes mellitus J. Pediatr. Endocrinol. Metab. 16 2003 5 22
21. L.C. Groop, G.F. Bottazzo, and D. Doniach Islet cell antibodies identify latent type 1 Diabetes in patients aged 35-75 years at diagnosis Diabetes 35 1986 237 241
22. J.M. Oli, G.F. Bottazzo, and D. Doniach Islet cell antibodies and diabetes in Nigerians Trop. Geogr. Med. 33 1981 161 164
23. D.G. McLarty, I. Athaide, G.F. Bottazzo, A.M. Swai, and K.G. Alberti Islet antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans Diabetes. Res. Clin. Pract. 9 1990 219 224
24. P. Rheeder, R.P. Stolk, and D.E. Grobbee Ethinic differences in C-peptide levels and anti-GAD antibodies in South African patients with diabetic ketoacidosis Q. J. Med. 94 2001 39 43
25. V.R. Panz, W.J. Kalk, M. Zouvanis, and B.I. Joffe Distribution of autoantibodies to gluatamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa Diabet. Med. 17 2000 524 527
26. A. Gottsater, M. Landin-Olsson, A. Lernmark, P. Fernlund, and G. Sundkvisk Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients Acta Diabetol. 31 1994 226 231
27. M.N. Elbagir, M.A. Eltom, and C. Berne Classification of newly-onset IDDM and NIDDM in subjects aged 25-45 years in Sudan J. Intern. Med. 244 1998 443 450
28. A. Schiffrin, S. Suissa, P. Poussier, R. Guttmann, and G. Weitzner Prospective study of predictors of β-cell survival in Type 1 diabetes Diabetes 37 1988 920 925
29. G.V. Gill, and K.R. Huddle Patterns of insulin dependence in an African Diabetic Clinic Q. J. Med. 81 1991 829 835
30. G.V. Gill, and K.R. Huddle Patterns and problems of diabetes in Soweto Cent. Afr. J. Med. 30 1984 189 195
31. R. Prando, P. Odetti, P. Melga, R. Guisti, E. Ciuchi, and V. Cheli Progressive deterioration of beta-cell function in non obese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency Diabetes Metab. 22 1996 185 191